Archives
-
EdU Imaging Kits (Cy3) for Tumor Cell Studies
2026-08-27
EdU Imaging Kits (Cy3) convert DNA replication into a bright, denaturation-free Cy3 signal for microscopy or flow cytometry. This workflow is especially useful for testing astragaloside IV responses in pituitary tumor models while separating reduced proliferation from apoptosis.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-26
The reference study identifies CLCC1 as a host factor required for the membrane-fusion step of herpesvirus nuclear egress, resolving a major gap between viral budding and capsid release into the cytoplasm. A whole-genome CRISPR screen with HSV-1 connects CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and defects in nuclear pore complex insertion, suggesting an ancient membrane-remodeling function.
-
Exemestane Workflows for Aromatase Research
2026-08-26
Build reproducible aromatase assays and hormone-dependent breast cancer models around Exemestane, a steroidal aromatase inhibitor with irreversible target engagement. This practical guide connects enzyme inhibition, washout experiments, biomarker-defined models, and troubleshooting for stronger estrogen biosynthesis studies.
-
Pseudo-UTP: Designing Better mRNA Experiments
2026-08-25
Pseudo-UTP is a pseudouridine-containing nucleotide for controlled mRNA synthesis and RNA stability enhancement. This article connects nucleotide chemistry with antigen-design decisions, assay controls, and practical workflow planning for mRNA vaccine development and gene therapy RNA modification.
-
Alosetron in Intestinal Polarity Research
2026-08-25
Alosetron provides a temporally controllable 5-HT3 receptor antagonist workflow for separating serotonin-driven gastrointestinal responses from epithelial stem-cell and polarity phenotypes. This guide integrates receptor pharmacology with CDC42–YAP–EGF–mTOR assay design, emphasizing practical dosing, controls, and troubleshooting rather than implying an unproven direct pathway connection.
-
How Sodium Overload Drives NECSO
2026-08-24
Qiao and colleagues identify a mitochondrial mechanism linking TRPM4-mediated sodium influx to necrosis by sodium overload, or NECSO. The study shows that mitochondrial sodium accumulation disrupts NCLX-dependent calcium handling, oxidative phosphorylation, and TCA-cycle activity, producing ATP failure and eventual loss of cellular integrity.
-
Sulfo-NHS-SS-Biotin Kit: Reliable Surface Assays
2026-08-24
Learn how Sulfo-NHS-SS-Biotin Kit (SKU K1006) supports reversible protein labeling, cell-surface studies, purification, and orthogonal interpretation of viability or cytotoxicity experiments. This scenario-based guide covers chemistry, workflow parameters, data controls, and practical vendor-selection criteria.
-
Alosetron in Gut Signaling Research
2026-08-23
Explore how Alosetron, a selective 5-HT3 receptor antagonist, can be used to interrogate gut receptor signaling without conflating it with CDC42-driven epithelial polarity. This article translates intestinal stem-cell findings into practical assay design and interpretation.
-
Ivermectin: Assay Design from Parasites to PDAC
2026-08-22
Ivermectin is a broad-spectrum anti-parasitic research compound whose value depends on rigorous exposure, handling, and endpoint design. This guide uses a recent Gasdermin C study to show how mechanistic validation can improve parasitology assays without overstating oncology applications.
-
Tacrolimus (FK506) Experimental Workflow Guide
2026-08-21
Build more reproducible calcineurin-inhibition assays with Tacrolimus (FK506), from solvent preparation and T-cell stimulation to cytokine readouts and animal-model translation. The workflow separates literature-backed dosing from practical optimization, while using cyclosporine-resistance genetics to sharpen mechanistic interpretation.
-
Stattic Workflows for STAT3 Signaling Research
2026-08-21
Stattic is a practical STAT3 inhibitor for connecting pathway mechanism with apoptosis, radiosensitization, and treatment-resistance assays. This guide translates STAT3 biology into reproducible cell-based workflows while showing how microbiome-driven signaling findings can inform cancer biology experiments.
-
Hypoxia, Immunometabolism, and Tumor Redox Biology
2026-08-20
This 2025 review presents tumor hypoxia as an organizing force that links metabolic reprogramming, nutrient competition, immune-cell dysfunction, and immunosuppressive microenvironment formation. Its main practical implication is that tumor metabolism and immune metabolism should be studied as an interacting system, with spatially and redox-aware measurements used to evaluate therapeutic responses.
-
mRNA Vaccine Protects Dairy Cows From H5N1
2026-08-20
A hemagglutinin-based mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge without detectable effects on health or milk production. The study is notable for demonstrating durable protection in a production-relevant host, including protection in some animals despite very low late serum antibody levels.
-
Poria cocos, NRF2, and Ferroptosis in ALD
2026-08-19
The reference study identifies NRF2-regulated ferroptosis as a mechanistic link between oxidative stress and alcoholic liver disease, showing that Poria cocos polysaccharides reduce liver injury in alcohol-exposed rat and cell models. Its use of ferrostatin-1 and ML385 provides pharmacological support for a protective pathway involving NRF2 activation, iron handling, lipid peroxidation, and inflammatory signaling.
-
Light-Inducible RNA Release for Gene Therapy Control
2026-08-19
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that regulates mammalian translation without requiring a separate transcriptional effector domain. In mouse models, LIRP-based switches controlled therapeutic activity in skin and retina, showing how light-accessible gene regulation could improve temporal control and safety in gene therapy.